(Q43040784)

12 November 2017

Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Tong MJ

1

1 reference

12 November 2017

Hwang SJ

2

1 reference

12 November 2017

Lefkowitz M

3

1 reference

12 November 2017

Lee SD

4

1 reference

12 November 2017

Co RL

5

1 reference

12 November 2017

Conrad A

6

1 reference

12 November 2017

Schmid P

7

1 reference

12 November 2017

Lo KJ

8

1 reference

12 November 2017

1 November 1994

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

1 reference

12 November 2017

9

1 reference

12 November 2017

587-591

1 reference

12 November 2017

6

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Ribavirin: An antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

A phase 1 study of ribavirin in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Selective inhibition of functional lymphocyte subpopulations by ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

Ribavirin treatment for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

A pilot study of ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1994.TB01566.X

10.1111/J.1440-1746.1994.TB01566.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference